Around
4,000
people
4,000
people
CONMED's History of Innovation
Inventing for impact
A Legacy of Purposeful Innovation
From our humble beginnings at a kitchen table more than 50 years ago, CONMED has evolved into a global leader driven by a singular mission: improving patient outcomes through accessible, high-impact medical technology. Our history is defined by intentional growth and a commitment to clinical excellence across the surgical suite.
By strategically acquiring or developing clinically-advanced portfolios, we ensure that healthcare providers have the dependable tools they need to solve today’s most complex medical challenges. At CONMED, we don’t just innovate for the sake of technology; we innovate for the people who use it and the patients who depend on it.Impactful Acquisitions and Strategic Partnerships
We acquire with intention, focusing on technology that advances procedures and outcomes.
2022 Biorez
The addition of Biorez and its proprietary BioBrace® Reinforced Implant represents an important step forward for CONMED in advancing the next generation of soft tissue healing in sports medicine.
2022 In2Bones Global, Inc.
This acquisition enhances CONMED’s solutions for the treatment of disorders and injuries in upper and lower extremities. The company’s comprehensive product portfolio includes implants, fracture fixation, arthroplasty, biologics, and related hardware. It is now known as CONMED Foot and Ankle.
2019 Buffalo Filter
With the acquisition of Buffalo Filter, a leading surgical smoke evacuation and filter technology company, CONMED cements its spot as the leader in surgical smoke management solutions.
2016 SurgiQuest
CONMED furthers its commitment to continuous innovation with the acquisition of SurgiQuest and its flagship AirSeal® product - an innovative and clinically-backed insufflator that transforms laparoscopic procedures and outcomes.
2011 Musculoskeletal Transplant Foundation
An agreement with Musculoskeletal Transplant Foundation, the world’s largest tissue bank, gives us exclusive rights to their game-changing sports medicine allograft tissue.
2004 Bard
By acquiring the majority of the gastroenterology and pulmonary business from C.R. Bard, CONMED expands its presence in the general surgery market.
1997 Linvatec
CONMED more than doubles in size with the acquisition of Linvatec, which includes Hall® Power. This forward-looking diversification helps grow an international footprint.
A History of Market Firsts
CONMED has a strong heritage of bringing industry-changing products to market that raise the standard of care and efficiency.
AirSeal® iFS
AirSeal® iFS
The only* insufflator proven to improve procedures and outcomes
Autoclavable Camera Head
Autoclavable Camera Head
This first autoclavable camera head streamlined sterilization and boosted efficiency
Concept Shavers
Concept Shavers
First single-use arthroscopic shaver blade
Hall® Lithium Batteries
Hall® Lithium Batteries
First and only* UL-approved, fully autoclavable lithium batteries
Spectrum® Suture Passer
Spectrum® Suture Passer
This patented suture passing system is the most versatile system on the market
Surgairtome®
Surgairtome®
First high-speed pneumatic drill
Y-Knot® RC
Y-Knot® RC
First self-punching all-suture anchor
Zone Specific II Meniscal Repair Device
Zone Specific II Meniscal Repair Device
This meniscal repair device was the first to eliminate the need for open procedures
Going Global
While our headquarters moved from Utica, NY to Largo, FL, our impact has been spreading across the world.
More than
20
global locations
20
global locations
Manufacturing
in the
US and
Mexico
in the
US and
Mexico
Teams in
Asia
Australia
Europe
Latin America
Middle East
North America
Asia
Australia
Europe
Latin America
Middle East
North America
Our Mission Never Changed
Through six decades of growth, change, and remaking ourselves again and again, our mission never shifted. It's not all about the acquisitions or the product names. It's a focus on enabling healthcare providers around the world to deliver exceptional outcomes for patients.
That was the idea behind our first disposable ECG electrode in 1973, and the idea behind every single step CONMED took after that. Not to own the market, but to give healthcare providers what they actually needed to do their jobs with confidence and precision, so that patients could recover, go home, and get back to their lives.
That's the whole point. It always has been.
What do healthcare providers need that they don't have yet?
CONMED is still asking it.
This Is CONMED.
*Based on 2022 market analysis.